The anti-cancer properties of Modified Citrus Pectin.


Modified Citrus Pectin (MCP) is a form of pectin derived from citrus fruits that has been specially modified to make it more soluble. It has been studied as a potential treatment for cancer, as well as other diseases, due to its ability to bind to certain proteins and carbohydrates. MCP has been shown to be effective in reducing the spread of cancer cells and has even been shown to reduce the size of tumors in some cases. Additionally, MCP has been studied for its use in reducing side effects from chemotherapy and radiation treatments, as well as its potential to support immune system health.

Some studies show 
Gal-3 inhibition by Modified Citrus Pectin {study/study/study/study}. Gal-3 is over-expressed on the surface of cancer cells. High levels of Gal-3 cause cancer to grow and metastasize. In addition, MCP can stimulate the immune system increasing the activity of Natural Killer (NK) cells.

Research shows that Modified Citrus Pectin works by inhibiting processes involved in cancer progression:
  • MCP may suppress metastasis.
  • angiogenesis
  • anti-inflammatory: the pectin in modified citrus pectin ferments and forms butyric acid. {ref}
In addition:
  • MCP may induce caspase-3 dependent apoptosis. (caspase-3)
  • detoxification {ref}

Synergy with Honokiol

References & Sources


No comments:

Post a Comment